News | July 27, 2012

Elekta Grant to Support Pediatric Cancer Research in Spain

€32,000 bequest given to Madrid Hospital Foundation for research at Madrid’s Montepríncipe Hospital

July 27, 2012 — To support research exploring childhood cancers, Elekta has given a €32,000 ($40,000) grant to Madrid Hospital Foundation’s pediatric oncology program at the Madrid Montepríncipe Hospital's pediatric oncology and hematology unit. The donation was collected at a charity party held in conjunction with the 2012 Annual Meeting of the European Society for Radiotherapy and Oncology (ESTRO) in Barcelona. The foundation’s pediatric oncology research programs focus on increasing the understanding of cancer in children, and on improving treatment methods and the patient’s quality of life.

“Because cancer occurs more often in adults than in children, most of today’s technological developments in radiation therapy focus on adult patients and their needs,” said Tomas Puusepp, president and CEO of Elekta. “To address this imbalance, we are pleased to support the efforts of worthy pediatric cancer research programs such as the foundation’s pediatric oncology program. Elekta’s own efforts are aimed at adapting radiation therapy treatments to children, such as developing more suitable immobilization devices and imaging strategies, and by studying how to adjust doses for pediatric patients. To that end, we recently created the Elekta Pediatric Research Group, whose mission is to identify, develop and adapt products to treat childhood cancer."

Elekta’s products are currently not approved for use on children.

For more information:

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init